topotecan has been researched along with Renal Insufficiency in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, D; Guillot, A; Homans, AC; Iacono, LC; McCune, JS; Stewart, CF | 1 |
| Seiter, K | 1 |
| Figueroa, JA; Herrington, JD; Kirstein, MN; Stewart, CF; Zamboni, WC | 1 |
1 review(s) available for topotecan and Renal Insufficiency
| Article | Year |
|---|---|
Toxicity of the topoisomerase I inhibitors.
Topics: Camptothecin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Irinotecan; Renal Insufficiency; Topoisomerase I Inhibitors; Topotecan | 2005 |
2 other study(ies) available for topotecan and Renal Insufficiency
| Article | Year |
|---|---|
Topotecan disposition in an anephric child.
Topics: Antineoplastic Agents; Child; Cyclophosphamide; Enzyme Inhibitors; Humans; Kidney Neoplasms; Male; Renal Dialysis; Renal Insufficiency; Topoisomerase I Inhibitors; Topotecan; Wilms Tumor | 2004 |
Effect of hemodialysis on topotecan disposition in a patient with severe renal dysfunction.
Topics: Antineoplastic Agents; Female; Humans; Middle Aged; Ovarian Neoplasms; Renal Dialysis; Renal Insufficiency; Topotecan | 2001 |